Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use
Zoltán Papp(University of Debrecen), Bojan Vrtovec(Ljubljana University Medical Centre), Dirk von Lewinski(Medical University of Graz), Cândida Fonseca, Matthias Heringlake(University of Lübeck), Sundeep Kaul(National Health Service), Alain Rudiger(University Hospital of Zurich), María G. Crespo‐Leiro(Complexo Hospitalario Universitario A Coruña), Antoine Herpain(Université Libre de Bruxelles), J. Álvarez(Universidade de Santiago de Compostela), Stefan Bouchez(Ghent University Hospital), Sven‐Erik Ricksten(University of Gothenburg), Matti Kivikko, Gerhard Wikström(Uppsala University), Dulce Brito(University of Lisbon), Pentti Põder, С.Т. Мацкеплишвили(Lomonosov Moscow State University), Kristjan Karason(Sahlgrenska University Hospital), Gerhard Pölzl(Innsbruck Medical University), Hynek Říha(Institute of Clinical and Experimental Medicine), Leo Heunks(Amsterdam University Medical Centers), Višnja Ivančan(University Hospital Centre Zagreb), Josep Comín‐Colet(Instituto de Salud Carlos III), Markku S. Nieminen(Cornell University), Dimitrios Farmakis(National and Kapodistrian University of Athens), Sonja Fruhwald(Medical University of Graz), Wolfgang Toller(Intensive Care Foundation), Francesco Fedele(Sapienza University of Rome), Jacek Kubica(Nicolaus Copernicus University), Fabio Guarracino(Azienda Ospedaliera Universitaria Pisana), Dominique Béttex(University Hospital of Zurich), Robert H. G. Schwinger(Klinikum Weiden), Massimo Girardis(University of Modena and Reggio Emilia), Piergiuseppe Agostoni(University of Milan), Luigi Tritapepe(Carlo Forlanini Hospital), Juan F. Delgado(Universidad Complutense de Madrid), Alexandre Mebazaa(Délégation Paris 5), John Parissis(National and Kapodistrian University of Athens), Alexander Reinecke(University Hospital Schleswig-Holstein), Carsten Tschöpe(Berlin-Brandenburger Centrum für Regenerative Therapien), Vladimír Černý, Fabrizio Oliva(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Alexander A Eremenko(Sechenov University), István Édes(University of Debrecen), Josep Masip(Consorci Sanitari Garraf), Veli‐Pekka Harjola(Polskie Towarzystwo Gastroenterologii), Julius-Gyula Papp(University of Szeged), Toni Sarapohja(Orion Corporation (Finland)), Tryggve Husebye(Oslo University Hospital), Alexander Parkhomenko
Cited by 67
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k